Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michihisa Kono, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nagato T, Komatsuda H, Hayashi R, Takahara M, Kishibe K, Yasuda S, Yajima Y, Kosaka A, Ohkuri T, Oikawa K, Harabuchi S, Kono M, Yamaki H, Wakisaka R, Hirata-Nozaki Y, Ohara K, Kumai T, Katada A, Hayashi T, Harabuchi Y, Kobayashi H. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. Cancer Immunol Immunother. 2023 Feb 22. PMID: 36811663.
    Citations:    Fields:    
  2. Komatsuda H, Wakisaka R, Kono M, Kumai T, Hayashi R, Yamaki H, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Takahara M, Katada A, Kobayashi H. Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation. Cancer Sci. 2023 Feb; 114(2):399-409. PMID: 36285482; PMCID: PMC9899601.
    Citations: 1     Fields:    Translation:HumansCells
  3. Kono M, Saito S, Egloff AM, Allen CT, Uppaluri R. The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations. Oral Oncol. 2022 09; 132:106012. PMID: 35820346; PMCID: PMC9364442.
    Citations:    Fields:    Translation:HumansAnimalsCells
  4. Suzuki S, Bandoh N, Goto T, Kubota A, Uemura A, Kono M, Sato R, Takeda R, Sakaue S, Yamaguchi-Isochi T, Nishihara H, Takei H, Harabuchi Y. A retrospective study of parotid gland tumors at a single institution. Oncol Lett. 2022 Jul; 24(1):207. PMID: 35720490.
  5. Ohara K, Katada A, Kumai T, Ominato H, Hirata-Nozaki Y, Sabusawa T, Yamaki H, Kono M, Komatsuda H, Wakisaka R, Takahara M, Hayashi T, Harabuchi Y. Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases. Auris Nasus Larynx. 2022 May 11. PMID: 35568581.
    Citations:    Fields:    
  6. Kono M, Yamaki H, Komatsuda H, Kumai T, Hayashi R, Wakisaka R, Sato R, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Harabuchi Y. IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer. Transl Oncol. 2022 Apr; 18:101358. PMID: 35123188; PMCID: PMC8819385.
    Citations: 1     
  7. Kumai T, Yamaki H, Kono M, Hayashi R, Wakisaka R, Komatsuda H. Antitumor Peptide-Based Vaccine in the Limelight. Vaccines (Basel). 2022 Jan 03; 10(1). PMID: 35062731.
    Citations: 1     
  8. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022; 11(1):2021619. PMID: 35003900.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  9. Kumai T, Komatsuda H, Wakisaka R, Yamaki H, Kono M, Hayashi R, Kishibe K, Takahara M, Katada A, Hayashi T, Harabuchi Y. Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma. Clin Otolaryngol. 2022 01; 47(1):228-233. PMID: 34657397.
    Citations:    Fields:    Translation:Humans
  10. Bandoh N, Katada A, Kono M. Endoscopic Endonasal and Transmaxillary Approach for Resection of Juvenile Nasopharyngeal Angiofibroma With Preoperative Embolization in a Child. J Craniofac Surg. 2021 Jul-Aug 01; 32(5):e510-e513. PMID: 33534320.
    Citations:    Fields:    Translation:Humans
  11. Kono M, Kumai T, Hayashi R, Yamaki H, Komatsuda H, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Kobayashi H, Harabuchi Y. Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery. Cancer Immunol Immunother. 2021 Dec; 70(12):3421-3434. PMID: 33866408.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  12. Hayashi R, Nagato T, Kumai T, Ohara K, Ohara M, Ohkuri T, Hirata-Nozaki Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchi Y, Kobayashi H. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma. Oncoimmunology. 2020 12 29; 10(1):1856545. PMID: 33457076.
    Citations: 5     Fields:    Translation:HumansCells
  13. Kono M, Wakisaka R, Kumai T, Hayashi R, Komatsuda H, Sato R, Abe Y, Yamaki H, Takahara M, Katada A, Hayashi T, Harabuchi Y. Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy. Head Neck. 2021 02; 43(2):514-519. PMID: 33015926.
    Citations: 4     Fields:    Translation:Humans
  14. Bandoh N, Ichikawa H, Asahi A, Kono M, Harabuchi S, Sato R, Uemura A, Goto T, Yamaguchi T, Kato Y, Furukawa H, Takei H, Harabuchi Y. Lung Adenocarcinoma with Cheek Dysesthesia as an Initial Symptom: A Case Report and Literature Review. Case Rep Oncol. 2019 May-Aug; 12(2):650-656. PMID: 31572154.
    Citations: 1     
  15. Bandoh N, Akahane T, Goto T, Kono M, Ichikawa H, Sawada T, Yamaguchi T, Nakano H, Kawase Y, Kato Y, Kamada H, Harabuchi Y, Shimizu K, Nishihara H. Targeted next-generation sequencing of cancer-related genes in thyroid carcinoma: A single institution's experience. Oncol Lett. 2018 Dec; 16(6):7278-7286. PMID: 30546467.
    Citations: 12     
  16. Kono M, Bandoh N, Matsuoka R, Goto T, Akahane T, Kato Y, Nakano H, Yamaguchi T, Harabuchi Y, Nishihara H. Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review. Head Neck Pathol. 2019 Sep; 13(3):298-303. PMID: 30206803.
    Citations: 10     Fields:    Translation:Humans
  17. Harabuchi S, Bandoh N, Yasukawa R, Kono M, Goto T, Harabuchi Y, Ikeda H, Kamada H, Nishihara H. ANCA-Negative Granulomatosis with Polyangiitis Presenting with Hypertrophic Cranial Pachymeningitis, Abducens Nerve Palsy, and Stenosis of the Internal Carotid Artery. Case Rep Otolaryngol. 2017; 2017:9687383. PMID: 29527371.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kono's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (56)
Co-Authors (3)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.